TIDMVRE
RNS Number : 3305T
VR Education Holdings PLC
14 November 2019
14 November 2019
VR Education Holdings plc
('VR Education' or the 'Group')
Further roll-out of ENGAGE platform with renowned global
partners
Oxford University, HTC, KWTRP partner with VR Education to train
doctors and nurses to save lives
VR Education (AIM: VRE; Euronext Growth: 6VR), a leading virtual
reality ('VR') technology company focused on the education and
enterprise training space, is pleased to announce that the Group's
ENGAGE platform has been selected by Life-saving Instruction for
Emergencies (LIFE), which launches today at the Council of
International Neonatal Nurses (COINN) conference in Nairobi, Kenya.
LIFE is a VR medical training app developed by doctors, nurses and
researchers at Oxford University and the KEMRI-Welcome Trust
Research Programme (KWTRP) in Kenya, with support from HTC and VR
Education.
LIFE allows healthcare workers to enter a realistic 3D virtual
hospital on their own smartphones or using a virtual reality
headset, such as the HTC Vive. Using the app, healthcare
professionals can practice life-saving skills on virtual patients
so that they are ready to act quickly and effectively in a real
emergency. In low-resource settings, access to simulation training
can be difficult and expensive and it is in this situation that
using VR for training could dramatically improve outcomes by
enabling more healthcare workers to receive the high-quality
training they need to save lives.
In 2017, the LIFE project won the 'VR for Impact' competition,
sponsored by HTC, at the World Economic Forum in Davos. It is now
supported by a wide range of global health organisations including
the Wellcome Trust, Médecins Sans Frontières, USAID, DFID and the
Bill and Melinda Gates Foundation. The momentum from the win has
enabled the LIFE team to create a new VR version of the LIFE app
that runs on the ENGAGE platform and uses the new HTC VIVE Focus
Plus headset.
The VR version of LIFE follows the launch of the smartphone
version in April 2019. The LIFE smartphone app is now being rolled
out across Kenya through partnerships with medical and nursing
schools and professional organisations such as the Kenya Paediatric
Association. The platform has been extensively tested in beta, with
thousands of healthcare workers already using the app on their
smartphones.
David Whelan, CEO of VR Education, commented: "Operating via our
versatile ENGAGE platform, LIFE has been designed to provide
healthcare workers with universal access to high quality medical
education and offers the potential to dramatically promote access
to life-saving knowledge in developing nations. Working with
leading medical experts at Oxford University and delivering
real-world applications using immersive technology puts us at the
forefront of scaling difficult to teach training scenarios such as
medical training and this is a significant first step for VR
Education. Supporting LIFE on a pro bono basis will increase
awareness of our ENGAGE platform with medical professionals and
students which we are confident will lead to enquiries from medical
trainers seeking to host their own applications on the ENGAGE
platform on a paid basis."
Dr Chris Paton, the lead researcher for LIFE from the University
of Oxford, commented: "The rapid adoption of smartphones by
thousands of healthcare workers across Africa means that they now
have the chance to access training that would have been too
expensive to access using traditional face-to-face courses. By
using immersive VR simulation training in combination with a
personal smartphone app, the LIFE project has the potential to
support healthcare worker training at scale."
- Ends -
For further information, please contact:
VR Education Holdings plc Tel: +353 87 665 6708
David Whelan, CEO contact@vreducationholdings.com
Sandra Whelan, COO
Cairn Financial Advisers LLP (Nominated Tel: +44 (0) 20 7213
Adviser) 0880
James Caithie / Liam Murray / Ludovico
Lazzaretti
Shore Capital (Joint Broker) Tel: +44 (0) 20 7408
Toby Gibbs / Anita Ghanekar (Corporate 4090
Advisory)
Fiona Conroy (Corporate Broking)
Davy (Joint Broker & Euronext Growth Tel: +353 1 679 6363
Advisor)
Fergal Meegan / Ronan Veale / Barry
Murphy
Buchanan (UK Financial PR) Tel: +44 (0)20 7466 5000
Henry Harrison-Topham / Chris Lane VRE@buchanan.uk.com
/ Tilly Abraham
Notes to Editors
About VR Education Holdings PLC
VR Education, together with its wholly owned subsidiary, is an
early stage VR software and technology group based in Waterford,
Ireland, dedicated to transforming the delivery methods of
education and corporate training by utilising VR technologies to
deliver fully immersive virtual learning experiences. The Group's
core focus is the development and commercialisation of its online
virtual social learning and presentation platform called ENGAGE,
which provides a platform for creating, sharing and delivering
proprietary and third-party VR content for educational and
corporate training purposes.
In addition to the ongoing development of the ENGAGE platform,
the Group has also built two downloadable showcase VR experiences,
being the award-winning Apollo 11 VR experience and the Titanic VR
experience.
On 12 March 2018, VR Education listed on the AIM market of the
London Stock Exchange and on the Enterprise Securities Market, a
market regulated by Euronext Dublin. For further information,
please visit www.vreducationholdings.com.
About LIFE
Life-saving Instruction for Emergences (LIFE) is a virtual
reality and smartphone app delivering medical training through
mobile and VR platforms. The platform was initially developed by
clinicians and researchers at the KEMRI-Wellcome Trust Research
Programme and the University of Oxford, and its development has
been supported by HTC, Oxford University Innovation, GCRF, the Bill
and Melinda Gates Foundation, the Wellcome Trust, Saving Lives at
Birth, VR Education PLC and Médecins Sans Frontières.
LIFE is available to download for free from
www.oxlifeproject.org for smartphones and Virtual Reality headsets
or search for "Life-saving Instruction for Emergencies" on the
Google Play Store.
Follow the LIFE project on twitter @oxlifeproject.org
About the University of Oxford
The Centre for Tropical Medicine and Global Health at the
University of Oxford is a collection of research groups permanently
based in Oxford, in Africa (Kenya, Uganda and DRC) and in Asia
(Thailand, Vietnam, Laos, Myanmar, Cambodia, Indonesia and Nepal).
Aiming to tackle infectious diseases, from malaria, TB and HIV to
neglected tropical diseases and emerging infections, our research
ranges from clinical studies to behavioural sciences, with capacity
building integral to all of our activities.
Oxford University has been placed number 1 in the Times Higher
Education World University Rankings for the fourth year running,
and at the heart of this success is our ground-breaking research
and innovation.
Oxford is world-famous for research excellence and home to some
of the most talented people from across the globe. Our work helps
the lives of millions, solving real-world problems through a huge
network of partnerships and collaborations. The breadth and
interdisciplinary nature of our research sparks imaginative and
inventive insights and solutions.
Through its research commercialisation arm, Oxford University
Innovation, Oxford is the highest university patent filer in the UK
and is ranked first in the UK for university spinouts, having
created more than 170 new companies since 1988. Over a third of
these companies have been created in the past three years.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
MSCBLBDBBXBBGCX
(END) Dow Jones Newswires
November 14, 2019 02:00 ET (07:00 GMT)
Grafico Azioni Vr Education (LSE:VRE)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Vr Education (LSE:VRE)
Storico
Da Apr 2023 a Apr 2024